Kenneth Kaitin is Professor of Medicine at Tufts University School of Medicine and Director of the Tufts Center for the Study of Drug Development. He’s also an Advisory Professor at Shanghai Medical College at Fudan University, and he serves on the faculty of the European Center for Pharmaceutical Medicine at the University of Basel. An internationally recognized expert in drug development science and policy, Dr. Kaitin writes, speaks, and teaches on global trends in pharmaceutical development and regulation, and he has provided public testimony before the US Congress. A former President of the Drug Information Association, Dr. Kaitin is Editor-in-Chief of Expert Review of Clinical Pharmacology, and a consultant to the US Department of Defense on bioterror countermeasures. In addition, Dr. Kaitin serves on several public and private company boards of directors. He received his BS from Cornell University and MS and PhD in pharmacology from the University of Rochester.